Biotech developing psychedelic compounds into licensed medicines.
| Date | Round | Amount |
|---|---|---|
| Aug 2021 | Series B UK psychedelics biotech Beckley Psytech raised a USD 80M Series B led by Integrated. | $80M |
| Dec 2020 | Series A UK psychedelic medicine developer Beckley Psytech raised GBP14M (about EUR15.5M) in an equity round with new investors Noetic Psychedelic Fund and Bail Capital. | $17.4M |